Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer.
Cervical cancer
Indocyanine green
Lymph node mapping
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
02
07
2019
accepted:
27
01
2020
pubmed:
13
2
2020
medline:
1
9
2020
entrez:
13
2
2020
Statut:
ppublish
Résumé
Lymph node metastasis is a significant predictive factor for disease recurrence and survival in cervical cancer patients and relevant for therapeutic strategies. We evaluated the clinical value of indocyanine green (ICG) by measuring the sensitivity and negative predictive value of sentinel lymph node mapping compared with the gold standard of complete lymphadenectomy in detecting lymph node metastases for cervical cancer. We utilized the near-infrared imaging agent ICG to detect tumor-infested lymph nodes in the pelvis analogue to a classical sentinel lymph node procedure by analyzing data from 20 patients who had undergone surgery for cervical cancer at our institution. A laparoscopic lymph node mapping procedure by means of ICG, followed by a complete pelvic lymphadenectomy with or without paraaortic lymphadenectomy was done in all patients. Histological examination identified seven patients with tumor-positive pelvic nodes, whereas mapping with ICG identified only five of these patients. Detection rate of positive nodes by ICG mapping and false negative rate was 71.4% and 28.6%, respectively; bilateral detection rate was 83.3%. One of the two false negative patients additionally suffered from deep infiltrating endometriosis. Our results indicate that ICG can identify the relevant pelvic nodes independent of tumor size, provided bilateral detection is achieved and additional, related diseases are excluded. This trial is registered within the German Clinical Trial Register (DRKS-ID: DRKS00014692).
Identifiants
pubmed: 32048031
doi: 10.1007/s00404-020-05457-x
pii: 10.1007/s00404-020-05457-x
doi:
Substances chimiques
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
787-792Références
https://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/ . Accessed June 2019
Robert Koch Institut. Krebs in Deutschland 2013/14, 11. Ausgabe. Gesundheitsberichterstattung des Bundes 2017. https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2017/krebs_in_deutschland_2017.pdf;jsessionid=7026C5FB7EAC6766D3B5BA35C01B5B05.1_cid298?__blob=publicationFile . Accessed June 2019
Cibula D, Abu-Rustum NR, Dusek L et al (2012) Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 124:496–501
doi: 10.1016/j.ygyno.2011.11.037
pubmed: 22120175
Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A (2007) Sentinel lymph node in vulvar cancer. Cancer 110:1015–1023
doi: 10.1002/cncr.22874
pubmed: 17626265
de Hullu JA, Doting E, Piers DA et al (1998) Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 39:1381–1385
pubmed: 9708512
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Langversion, 4.1, 2018, AWMF-Registernummer: 032/045OL, https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Mammakarzinom_4_0/Version_4.1/LL_Mammakarzinom_Langversion_4.1.pdf .Accessed Dec 2018
Tax C, Rovers MM, de Graaf C, Zusterzeel PL, Bekkers RL (2015) The sentinel node procedure in early stage cervical cancer, taking the next step: a diagnostic review. Gynecol Oncol 139:559–567
doi: 10.1016/j.ygyno.2015.09.076
pubmed: 26416173
Frumovitz M (2017) Sentinel lymph node biopsy for cervical cancer patients—what’s it gonna take? Gynecol Oncol 144:3–4
doi: 10.1016/j.ygyno.2016.12.009
pubmed: 28012545
Ramirez PT, Salvo G (2017) Molecular innovations in sentinel lymph node evaluation: moving beyond radiotracers and colored dyes. J Minim Invasive Gynecol 24:1–2
doi: 10.1016/j.jmig.2016.10.011
pubmed: 27989809
Salvo G, Ramirez PT, Levenback CF et al (2017) Sensitivity and negative pre-dictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol 145:96–101
doi: 10.1016/j.ygyno.2017.02.005
pubmed: 28188015
pmcid: 5873580
Cormier B, Diaz JP, Shih K et al (2011) Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. Gynecol Oncol 122:275–280
doi: 10.1016/j.ygyno.2011.04.023
pubmed: 21570713
pmcid: 4996075
Ditto A, Martinelli F, Bogani G, Papadia A, Lorusso D, Raspagliesi F (2015) Sentinel node mapping using hysteroscopic injection of indocyanine green and laparoscopic near-infrared fluorescence imaging in endometrial cancer staging. J Minim Invasive Gynecol 22:132–133
doi: 10.1016/j.jmig.2014.08.009
pubmed: 25135786
Lecuru F, Mathevet P, Querleu D et al (2011) Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 29:1686–1691
doi: 10.1200/JCO.2010.32.0432
pubmed: 21444878
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsch Krebshilfe, AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom. Langversion, 1.0, 2014, AWMF-Registernummer: 032/033OL, https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Zervixkarzinom/LL_Zervixkarzinom_Langversion_1.0.pdf . Accessed Dec 2018
Lennox GK, Covens A (2017) Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer? Gynecol Oncol 144:16–20
doi: 10.1016/j.ygyno.2016.08.337
pubmed: 27742472
M. Schmidt, R. Bares, W. Brenner, A. Buck, F. Grünwald, J. Kopp, B. J. Krause, O. Schober, J. Sciuk, F. Sudbrock, H. Wengenmair. Deutsche Gesellschaft für Nuklearmedizin (DGN). Handlungsempfehlung (S1-Leitlinie): Verfahrensanweisung für die technische Durchführung der nuklearmedizinischen Wächter-Lymphknoten-Diagnostik. Stand: 10/2014 –AWMF-Registernummer 031–033.
Barranger E, Coutant C, Cortez A, Uzan S, Darai E (2010) Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease. Ann Oncol 16:1237–1242
doi: 10.1093/annonc/mdi245
Rauch P, Merlin J-L, Leufflen L et al (2016) Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: cross-sectional real-life study in 1024 breast cancer patients. Int J Surg 33:177–181
doi: 10.1016/j.ijsu.2016.08.002
pubmed: 27504849
Kim JH, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH (2018) The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer. World J Surg Oncol 16(1):52
doi: 10.1186/s12957-018-1341-6
pubmed: 29523141
pmcid: 5845382
Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7(5):626–634
doi: 10.1016/j.cbpa.2003.08.007
pubmed: 14580568
Marshall MV, Rasmussen JC, Tan IC et al (2010) Near-infrared fluorescence imaging in humans with indocyanine green: a review and update. Open Surg Oncol J 2:12–25
pubmed: 22924087
pmcid: 3424734
Ietto G, Amico F, Soldini G, Chiappa C, Franchin M, Iovino D, Romanzi A, Saredi G, Cassinotti E, Boni L, Tozzi M, Carcano G (2016) Real-time intraoperative fluorescent lymphography: a new trechnique for lymphatic sparing surgery. Transplant Proc 48(9):3073–3078
doi: 10.1016/j.transproceed.2016.08.017
pubmed: 27932150
Beavis AL, Salazar-Marioni S, Sinno AK et al (2016) Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer. Gynecol Oncol 143:302–306
doi: 10.1016/j.ygyno.2016.08.236
pubmed: 27526991
pmcid: 5576021
Tanaka T, Terai Y, Ashihara K et al (2017) The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m- technetium-tin colloid, indocyanine green, and blue dye. J Gynecol Oncol 28:e13
doi: 10.3802/jgo.2017.28.e13
pubmed: 27894166
Elisei F, Crivellaro C, Giuliani D et al (2016) Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye. Ann Nucl Med 31:93–99
doi: 10.1007/s12149-016-1137-0
pubmed: 27815812
Buda A, Papadia A, Zapardiel I et al (2016) From conventional radiotracer Tc–99 with blue dye to indocyanine green fluorescence: a comparison of methods towards optimization of sentinel lymph node mapping in early stage cervical cancer for a laparoscopic approach. Ann Surg Oncol 23:2959–2965
doi: 10.1245/s10434-016-5227-y
pubmed: 27126631
Papathemelis T, Jablonski E, Scharl A, Hauzenberger T, Gerken M, Klinkhammer-Schalke M, Hipp M, Scharl S (2018) Sentinel lymph node biopsy in breast cancer patients by means of indocyanine green using the Karl Storz VITOM
Buda A, Papadia A, Di Martino G, Imboden S, Bussi B, Guerra L, De Ponti E, Reato C, Gasparri ML, Crivellaro C, Mueller M (2018) Real-time fluorescent sentinel lymph node mapping with indocyanine green in women with previous conization undergoing laparoscopic surgery for early invasive cervical cancer: comparison with radiotracer ± blue dye. J Minim Invasive Gynecol 25(3):455–460
doi: 10.1016/j.jmig.2017.10.002
pubmed: 29032256
https://www.krebsgesellschaft.de/gcs/german-cancer-society/certification.html . Accessed June 2019
https://www.ccc.uk-erlangen.de/ . Accessed June 2019
Jerman LF, Hey-Cunningham AJ (2015) The role of the lymphatic system in endometriosis: a comprehensive review of the literature. Biol Reprod 92(3):64–71
doi: 10.1095/biolreprod.114.124313
pubmed: 25588508
Buda A, Elisei F, Palazzi S et al (2016) Quality of care for cervical and endometrial cancer patients: the impact of different techniques of sentinel lymph node mapping on patient satisfaction. Ann Surg Oncol 23:2975–2981
doi: 10.1245/s10434-016-5233-0
pubmed: 27116680
Abu Khoury-Collado F, Glaser GE, Zivanovic O et al (2009) Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecol Oncol 115:453–455
doi: 10.1016/j.ygyno.2009.08.026